<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Hemolytic_Uremic_Syndrome_For_DeNovo_Initial_Initiation_Criteria_Q10</name>
        <optionSourceResponseValue>true</optionSourceResponseValue>
        <questionText>h) Medication induced TMA: provide a list of all medications the patient was exposed to within 1 month of disease onset. If this includes any of the following, a detailed explanation must be provided explaining why the current presentation is not secondary to medication-related TMA: 
a. Cisplatin; Gemcitabine; Mitomycin; Clopidogrel/ ticlopidine; Quinine; Interferon α,β; Anti-vascular endothelial growth factor; alemtuzumab; Cyclosporine / tacrolimus; Ciprofloxacin; Illicit drugs [e.g. cocaine, heroin, ecstasy]; proteasome inhibitors</questionText>
        <responseValues>Present
Absent</responseValues>
        <status>Active</status>
        <versionNumber>1</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>Hemolytic_Uremic_Syndrome_For_DeNovo_Initial_Initiation_Criteria_Q10</developerName>
    <name>Hemolytic_Uremic_Syndrome_For_DeNovo_Initial_Initiation_Criteria_Q10</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
